Relieve the Patient's Thirst, Refresh the Mouth First (ICU-MIC)
NCT ID: NCT03610074
Last Updated: 2019-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2018-04-23
2019-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Water, cold and mint applied in mouth were studied separately and were shown to decrease thirst significantly on animal models and healthy humans.
Therefore, the hypothesis of this study is that application of small mint ice cubes in mouth of very dehydrated ICU patients should allow decreasing quickly and significantly thirst for these patients, before the correction of their biological parameters, like natremia and osmolarity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Controlled Fluid Administration
NCT03176043
Thirst-guided Subject-controlled Rehydration in Healthy Volunteers
NCT03932890
Fluid Challenges in Intensive Care
NCT01787071
Oral Fluid Volume Expansion
NCT01360333
A Comparison of Three Commercial Oral Rehydration Solutions Consumed After Extra-cellular Dehydration
NCT05775055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mint ice cubes
Physician applies 3 mint ice cubes in mouth of highly dehydrated patient. Patient undergoes an additional blood test at 5 min from mint ice cubes application.
Physician performs patient's questioning before mint ice cubes application and at 5 min, 1h, 2h, 4h, 12h and 24h from mint ice cubes application.
Mint Ice Cube
Application in patient's mouth of 3 mint ice cubes
Blood test
Additional blood test 5 min after mint ice cubes application
Patient's questioning
Patient's questioning before mint ice cubes application and at 5 min, 1h, 2h, 4h, 12h and 24h from mint ice cubes application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mint Ice Cube
Application in patient's mouth of 3 mint ice cubes
Blood test
Additional blood test 5 min after mint ice cubes application
Patient's questioning
Patient's questioning before mint ice cubes application and at 5 min, 1h, 2h, 4h, 12h and 24h from mint ice cubes application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Estimated hospitalization duration in ICU upper than 24h
Exclusion Criteria
* Known mint allergy
* Incapability to understand study outcome and to answer basic questions
* Pregnancy
* Dying person
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Arras
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malcolm LEMYZE, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Arras
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier d'Arras
Arras, , France
Centre Hospitalier de Lens
Lens, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.